Janus Henderson Group
NRC icon

Janus Henderson Group’s NRC Health Common Stock NRC Stock Holding History

Janus Henderson Group’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,428
Closed -$254K – 2561
2024
Q1 		$254K Buy
6,428
+4
+0.1% +$158 ﹤0.01% 2303
2023
Q4 		$254K Sell
6,424
-12
-0.2% -$502 ﹤0.01% 2315
2023
Q3 		$286K Buy
6,436
+2
+0% +$87 ﹤0.01% 2204
2023
Q2 		$280K Sell
6,434
-39
-0.6% -$1.72K ﹤0.01% 2288
2023
Q1 		$281K Sell
6,473
-24,932
-79% -$1.1M ﹤0.01% 2310
2022
Q4 		$1.17M Sell
31,405
-2,534
-7% -$98K ﹤0.01% 1279
2022
Q3 		$1.35M Sell
33,939
-771
-2% -$28.5K ﹤0.01% 1182
2022
Q2 		$1.33M Buy
34,710
+6,298
+22% +$228K ﹤0.01% 1200
2022
Q1 		$1.13M Sell
28,412
-8,403
-23% -$329K ﹤0.01% 1444
2021
Q4 		$1.53M Buy
36,815
+2,455
+7% +$107K ﹤0.01% 1351
2021
Q3 		$1.45M Sell
34,360
-7,429
-18% -$374K ﹤0.01% 1311
2021
Q2 		$1.92M Sell
41,789
-5,904
-12% -$281K ﹤0.01% 1245
2021
Q1 		$2.23M Buy
47,693
+11,989
+34% +$583K ﹤0.01% 1165
2020
Q4 		$1.53M Buy
35,704
+3,532
+11% +$181K ﹤0.01% 1163
2020
Q3 		$1.58M Buy
32,172
+2,879
+10% +$159K ﹤0.01% 1091
2020
Q2 		$1.7M Buy
29,293
+14,012
+92% +$740K ﹤0.01% 1052
2020
Q1 		$695K Buy
15,281
+819
+6% +$49.2K ﹤0.01% 1149
2019
Q4 		$954K Buy
14,462
+8,365
+137% +$511K ﹤0.01% 1225
2019
Q3 		$352K Sell
6,097
-5,745
-49% -$356K ﹤0.01% 1324
2019
Q2 		$682K Buy
+11,842
New +$548K ﹤0.01% 1235
2019
Q1 		– Sell
-13,693
Closed -$522K – 1372
2018
Q4 		$522K Buy
13,693
+650
+5% +$25K ﹤0.01% 1223
2018
Q3 		$503K Buy
13,043
+7,037
+117% +$267K ﹤0.01% 1317
2018
Q2 		$225K Buy
+6,006
New +$209K ﹤0.01% 1359

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $26.8B AUM 3.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
QV Investors
QV Investors Calgary, Alberta, Canada $1.36B AUM 20.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Janus Henderson Group's NRC Position: Q2 2024 in Review

Janus Henderson Group sold out of NRC Health Common Stock (NRC) in Q2 2024, closing a stake of 6,428 shares — an estimated $254K sold.

Janus Henderson Group first reported a position in NRC in Q2 2018 and held it in 23 quarters. The position peaked at $2.23M in Q1 2021. 136 funds tracked by Wall St. Rank hold NRC as of Q2 2024.

  • Janus Henderson Group reported no remaining NRC Health Common Stock position as of Q2 2024 after selling out during the quarter.
  • Janus Henderson Group sold 6,428 NRC Health Common Stock shares in Q2 2024, an estimated $254K.
  • Janus Henderson Group first reported a position in NRC Health Common Stock in Q2 2018 and held it in 23 quarters.
  • Janus Henderson Group's NRC Health Common Stock position peaked at $2.23M in Q1 2021.
  • 136 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2024.

Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.